Drug Shortage Report for APO-LITHIUM CARBONATE

Last updated on 2024-12-20 History
Report ID 227079
Drug Identification Number 02242838
Brand name APO-LITHIUM CARBONATE
Common or Proper name LITHIUM CARBONATE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) LITHIUM CARBONATE
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 BTL
ATC code N05AN
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-30
Estimated end date 2024-12-20
Actual end date 2024-12-19
Shortage status Resolved
Updated date 2024-12-20
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-12-20 French Compare
v6 2024-12-20 English Compare
v5 2024-10-31 French Compare
v4 2024-10-31 English Compare
v3 2024-08-06 English Compare
v2 2024-05-03 French Compare
v1 2024-05-03 English Compare

Showing 1 to 7 of 7